SCHEMBL20689871

SCHEMBL20689871

c1ccc(N2c3ccccc3[Si]3(c4ccccc42)c2ccccc2C2(c4ccccc4N(c4ccc(-c5ccccn5)cc4)c4ccccc42)c2ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 3/20 0.40
▸ PDK2 Q15119 1/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ CYP2C9 P11712 3/20 0.33
▸ CYP2C19 P33261 3/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ GRIN2B Q13224 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ NPY5R Q15761 1/20 0.31
▸ HTR1A P08908 1/20 0.30
▸ HTR7 P34969 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ GRIA1 P42261 1/20 0.30
▸ GRIA3 P42263 1/20 0.30
▸ PDE4D Q08499 1/20 0.30
▸ GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20689873 0.88 ALDH1A1 (0.33) EGLN1CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL20689908 0.88 EGLN1 (0.45) EGLN1PDK2CYP1A2CYP2C9CYP2C19
SCHEMBL20689868 0.83 MEN1 (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL20689930 0.82 KDM4E (0.36) EGLN1CYP2C9ALDH1A1CYP3A4GRM5
SCHEMBL20689872 0.81 ALDH1A1 (0.36) PDK2CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL20689874 0.81 ALDH1A1 (0.35) CYP1A2CYP2C9CYP2C19CYP2D6ALDH1A1
SCHEMBL20689927 0.80 ALDH1A1 (0.38) PDK2CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL24293133 0.79 PDK2 (0.46) EGLN1PDK2CYP1A2CYP2C9CYP2C19
SCHEMBL20689848 0.79 CYP2A6 (0.46) EGLN1PDK2GRM5MAPT
SCHEMBL24646765 0.78 PDK2 (0.41) EGLN1PDK2ALDH1A1HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11018306-B2 Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-25 — — US disclosed
US-20190036034-A1 COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11018306-B2 Compound for thermally activated delayed fluorescence and organic electroluminescence device including the same TRPA1, SLCO2A1, TMEM109 EGLN1 2128/4885PDK2 773/4885CYP1A2 1396/4885
US-20190036034-A1 COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME TRPA1, SLCO2A1, TMEM109 EGLN1 2128/4885PDK2 773/4885CYP1A2 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback